Chinese-produced New Drugs Approved for Marketing in 2018:

(Source: NMPA website, company announcements)
Pharmaceutical product name | Trade name | Registration classification | Company | Approval date | Indication |
Recombinant Cytokine Gene Derived Protein Injection | Novaferon | Biological product for treatment 1 | Genova Inc. | Apr. 20, 2018 | HBV |
Anlotinib Hydrochloride Capsules | FOCUS V | Chemical drug 1 | Chiatai Tianqing | May 17, 2018 | Locally advanced or metastatic NSCLC |
Mecapegfilgrastim Injection | Aiduo | Biological product for treatment 9 | Hengrui Medicine | May 17, 2018 | Neutropenia |
Albuvirtide for Injection | Aikening | Chemical drug 1 | Frontier Biotechnologies | May 30, 2018 | HIV-1 |
Danoprevir Sodium Tablets | Ganovo | Chemical drug 1 | Ascletis | June 15, 2018 | HCV |
Pegylated Recombinant Interferon Variant Injection | Kailiwei | Biological product for treatment 9 | Beijing Kawin | July 6, 2018 | HCV |
Pyrotinib Maleate Tablets | Airuini | Chemical drug 1 | Hengrui Medicine | Aug. 17, 2018 | Human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer |
Fruquintinib Capsules | Elunate | Chemical drug 1 | Hutchison MediPharma | Sep. 13, 2018 | Colorectal cancer |
Toripalimab Injection | Tuoyi | Biological product for treatment 1 | Junshi Biosciences | Dec. 21, 2018 | Melanoma |
Sintilimab Injection | Tyvyt | Biological product for treatment 1 | Innovent | Dec. 27, 2018 | Classical Hodgkin's lymphoma |
Jinrong Xiaopi Granules | / | TCM 6.1 | Kangyuan Pharmaceutical | Dec. 27, 2018 | Read More
Related News
Made-in-China New Drugs: Breaking Through the RMB 4-Billion Battlefield
lezhi September 5, 2025 You may like
Manufacture Supply CAS 607-80-7 ISO Approved 98% Sesamin Black Sesame Seed Extract
Ac-Phe-OH/2018-61-3
Product Name: 1-(Ethoxycarbonyl)cyclopropanecarboxylic acid Product Code: TY201802203 Cas No.: 3697-
2018 Clean Room Anti Static Cleaning Uniform Clothes
2018 Lint Free Reusable Cleanroom Cleaning Mop
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Nurah Ekhlaque
Sep 19, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|










(All Rights Reserved)